OSN
FORT LAUDERDALE, Fla. - A study in Brazil has concluded that an anterior juxtascleral depot of anecortave acetate can significantly reduce IOP for at least 3 months in several types of glaucoma. "These are all severe cases, all patients without controlled IOP, despite using medication," Tiago S. Prata, MD, told Ocular Surgery News, in an interview at his poster at the Association for Research in Vision and Ophthalmology meeting here. "Most of them required surgery or additional medication, and instead of doing the surgery, we enrolled them in the study."